Control of the Opening of mPTP by Ex Vivo Measurements on Permeabilized Muscle Fibers (COMMEF) (COMMEF)
|ClinicalTrials.gov Identifier: NCT04209413|
Recruitment Status : Recruiting
First Posted : December 24, 2019
Last Update Posted : January 22, 2020
mPTP (Mitochondrial Permeability Transition Pore) is a channel formed by a protein complex integrated into the inner membrane of mitochondria. Its opening is related to the elevation of the intra-mitochondrial calcium concentration and will result in: a mitochondrial decoupling, a rupture of the metabolic gradient and the release of pro-apoptotic factors.
The objective of this study is the development of a new ex vivo technique for characterizing mPTP by a dual measurement combining oxygraphy and fluorimetry on permeabilized skeletal muscle fibers.
|Condition or disease||Intervention/treatment|
|Anterior Cruciate Ligament Injuries||Procedure: Patients referred for a knee ligamentoplasty|
The development of new expertise in the study of mPTP is part of an approach to optimize the processing of muscle samples. The aim of this work is to evaluate the feasibility and reproducibility of a method of analysis on muscle fibers only permeabilized, while coupling two complementary techniques, oxygraphy and fluorimetry. Its principle is based on the knowledge that the opening of the mPTP leads to an inhibition of respiration at the level of the complex I of the respiratory chain. This inhibition is the consequence of the escape from mitochondria of the reduced form of nicotinamide adenine dinucleotide (NADH, i.e. substrate of complex I) concomitant with the opening of mPTP. Thus, the oxygraphy must allow the observation of the inhibition of respiration synonymous with the non-availability of the substrate of the complex I and thus indirectly reflect the opening of the mPTP. For its part, the fluorimetry must allow, in the presence of a fluorescent calcium indicator (i.e. Calcium Green), the observation of the release of calcium synonymous with the opening of the mPTP.
Once validated, this technique should make it possible to evaluate in situ the sensitivity of mPTP to calcium. In a context of application within clinical protocols, the evaluation of the mPTP calcium sensitivity should contribute to a better understanding of the physiological and physio-pathological mechanisms of adaptation of muscle tissue.
|Study Type :||Observational|
|Estimated Enrollment :||40 participants|
|Official Title:||Control of the Opening of mPTP by Ex Vivo Measurements on Permeabilized Muscle Fibers|
|Actual Study Start Date :||January 20, 2020|
|Estimated Primary Completion Date :||November 2020|
|Estimated Study Completion Date :||February 2021|
- Procedure: Patients referred for a knee ligamentoplasty
- Determination of the mPTP calcium sensitivity mPTP [ Time Frame: day 0 ]The goal is to study the feasibility of a new method for the analysis of the calcium sensitivity of mPTP on non-phantomized permeabilized muscle fibers by coupled use of oxygen and fluorimetry techniques. Calcium quantity and time required to open mPTPs in permeabilized muscle fibers will be measured, in the presence or absence of ciclosporin A, observable by total inhibition of mitochondrial respiration (synonymous with release of NADH).
- Identification of mPTP opening discrimination factors [ Time Frame: Day 0 ]Evaluate the possibility of population discrimination by this new method of analysis (i.e. variability by age and duration of functional impotence before intervention of the amount of calcium required to open the mPTP).
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT04209413
|Contact: Lise LACLAUTREfirstname.lastname@example.org|
|CHU de Clermont-Ferrand||Recruiting|
|Clermont-Ferrand, France, 63000|
|Contact: Ruddy Richard email@example.com|
|Principal Investigator: Ruddy Richard|
|Sub-Investigator: Stéphane Descamps|
|Sub-Investigator: Stéphane Boisgard|
|Principal Investigator:||Ruddy Richard||University Hospital, Clermont-Ferrand|